(Q36317585)

13 August 2017

1 reference

title

Cholesterol in Alzheimer's disease (English)

1 reference

13 August 2017

0 references

Leila A Shobab

1

1 reference

13 August 2017

Ging-Yuek R Hsiung

series ordinal

2

1 reference

13 August 2017

Howard H Feldman

series ordinal

3

1 reference

13 August 2017

1 December 2005

1 reference

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

12

1 reference

13 August 2017

841-852

1 reference

Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Small vessel disease and Alzheimer's dementia: pathological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cognitive impairment and dementia 20 months after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Links between the pathology of Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Dietary fats and the risk of incident Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Serum lipoprotein levels, statin use, and cognitive function in older women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Statin Use and the Risk of Incident Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol homeostasis and function in neurons of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

HMG-CoA reductase inhibitors and coenzyme Q10.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

A fluid connection: cholesterol and Abeta

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol for synthesis of myelin is made locally, not imported into brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Genetic association of CYP46 and risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Increased ABCA1 activity protects against atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Genotypic Effect of the −565C>T Polymorphism in the ABCA1 Gene Promoter on ABCA1 Expression and Severity of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

mRNA expression of the ATP-binding cassette transporter subfamily A (ABCA) in rat and human brain capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Diagnostic use of cerebral and extracerebral oxysterols

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Statin effects on cholesterol micro-domains in brain plasma membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

The NP-C gene: a key to pathways of intracellular cholesterol transport.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Niemann-Pick disease type C.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol storage and tau pathology in Niemann–Pick type C disease in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Accumulation of flotillin‐1 in tangle‐bearing neurones of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol homeostasis failure as a unifying cause of synaptic degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol-dependent modulation of tau phosphorylation in cultured neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

High frequency of apolipoprotein E ?2 Allele in hemorrhage due to cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E dose-dependent modulation of beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Midlife cardiovascular risk factors and risk of dementia in late life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Fish, meat, and risk of dementia: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Dietary factors and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Omega-3 fatty acids and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Novel omega -- 3-derived local mediators in anti-inflammation and resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E genetic variation and Alzheimer's disease. a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Familial hypercholesterolemia and apolipoprotein E4

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Association between apolipoprotein E genotype and Alzheimer disease in African American subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Genetic variation of the APOE promoter and outcome after head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Association of apolipoprotein E polymorphism with outcome after head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Cholesterol depletion with physiological concentrations of a statin decreases the formation of the Alzheimer amyloid Abeta peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Pravastatin inhibits pro-inflammatory effects of Alzheimer's peptide Abeta(1-42) in glioma cell culture in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Pravastatin down-regulates inflammatory mediators in human monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Isoprenoids as mediators of the biological effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

Statin-associated memory loss: analysis of 60 case reports and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970248-9

7 January 2021

10.1016/S1474-4422(05)70248-9

Identifiers

DOI

1 reference

release_fubihrafxngsbpi2fvzeepxnai

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fubihrafxngsbpi2fvzeepxnai

24 November 2022

mapped directly with Wikidata item

1 reference